WINDLAS
Windlas Biotech Limited
Pharmaceuticals
Share price
₹1,036
Market cap
₹2,191 Cr
1Y return
▲ 13%
A leading pharmaceutical contract development and manufacturing organization, Windlas Biotech specializes in producing solid and liquid dosage forms for domestic and international clients. The company provides comprehensive CDMO services including product discovery, development, and commercial manufacturing of generic and complex generic medications. Its vertically integrated operations, technical capabilities, and focus on quality manufacturing distinguish it within India's pharmaceutical sector.
Investors holding Windlas Biotech Limited
Recent moves 3
Bandhan Mutual FundIncreased
Bandhan Mutual Fund increased its stake in Windlas Biotech Limited from 1.11% to 1.43% by buying 61,858 shares. The stake is worth ₹25.13 Cr based on the company's share price of ₹852.25.
Read more
ICICI Prudential Mutual FundDecreased
ICICI Prudential Mutual Fund decreased its stake in Windlas Biotech Limited from 5.19% to 3.42%, selling 3,89,179 shares. The value of the sold shares is approximately ₹33.17 Cr at ₹852.25 apiece.
Read more
ICICI Prudential Mutual FundDecreased
ICICI Prudential Mutual Fund sold 5,40,642 shares of Windlas Biotech for ₹43.12 crore at ₹797.55 apiece, decreasing its stake from 6.96% to 4.33% and crossing the 5% disclosure threshold.
Read more
Track the whales in Windlas Biotech Limited
Get alerted the moment a top investor buys or sells.
Get started